Aliye Esmaoğlu

Aliye Esmaoğlu

Auto-generated profile, based on publicly available information

Aliye Esmaoğlu

Department of Anesthesiology and Reanimation , Division of Intensive Care , School of Medicine , Erciyes University , Kayseri , Türkiye , erciyes.edu.tr

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2022 in Emergency Medicine International
Verified
Journal Article
Open access
PDF file
Emine ALP MEŞEEmine ALP MEŞE
Emine ALP MEŞE
ZGZeynep Burçin Gönen
Zeynep Burçin Gönen
KGKursat Gundogan
Kursat Gundogan
AEAliye Esmaoglu
Aliye Esmaoglu
LKLeylagul Kaynar
Leylagul Kaynar
MDMehmet Doganay
Mehmet Doganay
Purpose. Sepsis and septic shock are the major causes of death in intensive care units. This study aimed to evaluate the clinical safety and efficacy of mesenchymal stem cells (MSCs) in sepsis and septic shock patients. Methods. Ten patients were enrolled in the study. Adipose-derived MSC infusions were given (1×106/kg, on the 1st, 3rd, 5th, 7th, and 9th days of therapy) together with standard therapy. Before the MSC applications, blood samples were collected for cytokine assessment (TNF-α, IFN-γ, IL-2, IL-4, IL-6, IL-10). The clinical and laboratory improvements were recorded and compared with control groups selected retrospectively. The clinical trial was registered on 16.03.2022 with the registration number NCT05283317. Results. In the study group, the ages of patients ranged from 22 to 68 years, and APACHE II scores ranged from 14 to 42. In the control group, ages ranged from 22 to 80 years and their APACHE II scores were between 1435. The survival rate in the study group was 100 on the 14th day whereas it was 70 on the 28th day. A significant decrease in the SOFA score (adjusted), clinical, and laboratory improvements were observed during the MSC administration. However, no significant cytokine level changes were observed. In the control group, the survival rate of 20 patients was 70 on the 14th day, whereas 60 was on the 28th day. While deaths were observed in the control group in the first week of treatment, deaths in the MSCs group were observed between the 15th and 28th days. Conclusion. MSCs treatment may have a positive impact on the survival rates of sepsis during the early phase. However, further randomized controlled studies with a large group of patients are needed. Trial Registration. This trial is registered with ClinicalTrials.gov Identifier: NCT05283317.

30 April 2022 in Journal of Parenteral and Enteral Nutrition
Verified
Journal Article
Closed access
KGKursat Gundogan
Kursat Gundogan
FYFaruk S. Yucesoy
Faruk S. Yucesoy
NOnurhayat tugra Ozer
nurhayat tugra Ozer
STSahin Temel
Sahin Temel
SESerap Sahin Ergul
Serap Sahin Ergul
TZThomas Ziegler
Thomas Ziegler

26 July 2005 in Acta Anaesthesiologica Scandinavica
Verified
Journal Article
Closed access
PDF file
AAAli Tuğrul Akin
Ali Tuğrul Akin
FUF. Ugur
F. Ugur
YÖYusuf Özkul
Yusuf Özkul
AEA. Esmaoglu
A. Esmaoglu
IGI. Gunes
I. Gunes
HEH. Ergul
H. Ergul

1 January 2005 in Journal of Burn Care & Rehabilitation
Verified
Journal Article
Closed access
ACAtilla Coruh
Atilla Coruh
GGGalip K. Gunay
Galip K. Gunay
AEAliye Esmaoglu
Aliye Esmaoglu
A retrospective multifactorial epidemiological study of 742 patients admitted to Erciyes University Medical Faculty Burn Unit during a 7-year period between 1996 and 2002 is presented. The overall male-to-female ratio was 1.88:1. The highest-risk age group of burn injuries was 0 to 6 years (48.6%), with the greatest number of injuries occurring to children who were 2 to 3 years of age. Seasonal variations had no influence on the increased number of admissions to the burn unit. Scalding was the major cause of pediatric burns. Flame burns were the most frequent cause of burns in adults and the second-leading cause in children. Seventy-eight of the 742 patients died, with a mortality rate of 7.8 % in children and 12.6% and 19.23% in adult males and females, respectively. The overall mortality rate was 10.5%.

23 June 2020 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
KGKursat Gundogan
Kursat Gundogan
EKEmre Karakoç
Emre Karakoç
TTTurgut Teke
Turgut Teke
AZAvşar ZERMAN
Avşar ZERMAN
AEAliye Esmaoğlu
Aliye Esmaoğlu
MSMurat Sungur
Murat Sungur
Critically ill patients are at risk of developing gastrointestinal (GI) bleeding due to stress causing mucosal damage. Aim of the study was to determine the effect of oral/ enteral nutrition with or without concomitant pantoprazole on upper GI bleeding in low risk critically ill patients. This was a prospective, randomized, open-label, multicenter study conducted with intensive care unit (ICU) patients receiving oral/enteral nutritional support. Patients were randomly assigned into two groups including intervention group (received oral/EN plus pantoprazole) and control group (received only oral/EN). A total of 300 patients (intervention group: 152, control group: 148) participated in the study. Overall, 226 (75 %) patients were fed by oral and 74 (25%) patients fed by enteral tube. Median duration of nutritional support 4 (range: 2-33) days. Overt upper GI bleeding was noted only in one patient (0.65%) who was in the intervention group. The overall length of ICU stay of 4 (2-105) days, while ICU stay was significantly longer in the intervention group than in the control group (p=0.006). Our findings seems to indicate that in patients who are at low risk for GI bleeding and under oral/enteral nutritional support, the use of PPIs may not reduce the risk of bleeding, however these results are imprecise because of low event (GI bleeding) rate and limited power.

9 June 2023 in European Journal of Trauma and Emergency Surgery
Verified
Journal Article
Closed access
PDF file
HAHamiyet Donmez Altuntas
Hamiyet Donmez Altuntas
SESerap Sahin Ergul
Serap Sahin Ergul
PAPinar Altin-Celik
Pinar Altin-Celik
KBKadir Bulut
Kadir Bulut
HEHamiyet Eci̇rOglu
Hamiyet Eci̇rOglu
KGKursat Gundogan
Kursat Gundogan